3/28
08:40 am
tenx
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results [Yahoo! Finance]
3/28
08:30 am
tenx
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
Medium
Report
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
3/12
08:52 am
tenx
Tenax Therapeutics to Present at the 36th Annual Roth Conference [Yahoo! Finance]
Neutral
Report
Tenax Therapeutics to Present at the 36th Annual Roth Conference [Yahoo! Finance]
3/12
08:30 am
tenx
Tenax Therapeutics to Present at the 36th Annual Roth Conference
Low
Report
Tenax Therapeutics to Present at the 36th Annual Roth Conference
2/29
09:19 am
tenx
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024 [Yahoo! Finance]
Medium
Report
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024 [Yahoo! Finance]
2/29
09:00 am
tenx
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Medium
Report
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
2/20
12:10 pm
tenx
Tenax Therapeutics, Inc. (NASDAQ: TENX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $30.00 price target on the stock.
Low
Report
Tenax Therapeutics, Inc. (NASDAQ: TENX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $30.00 price target on the stock.
2/20
08:38 am
tenx
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan [Yahoo! Finance]
Medium
Report
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan [Yahoo! Finance]
3/28
02:03 pm
tenx
Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31
Low
Report
Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31
3/28
08:45 am
tenx
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 28
Medium
Report
Form 8-K TENAX THERAPEUTICS, INC. For: Mar 28
2/26
04:33 pm
tenx
Form 424B3 TENAX THERAPEUTICS, INC.
Medium
Report
Form 424B3 TENAX THERAPEUTICS, INC.
2/26
04:33 pm
tenx
Form 424B3 TENAX THERAPEUTICS, INC.
Medium
Report
Form 424B3 TENAX THERAPEUTICS, INC.
2/23
04:34 pm
tenx
Form 8-K TENAX THERAPEUTICS, INC. For: Feb 22
Medium
Report
Form 8-K TENAX THERAPEUTICS, INC. For: Feb 22
2/21
05:40 pm
tenx
Form 424B3 TENAX THERAPEUTICS, INC.
Medium
Report
Form 424B3 TENAX THERAPEUTICS, INC.
2/21
05:36 pm
tenx
Form 424B3 TENAX THERAPEUTICS, INC.
Medium
Report
Form 424B3 TENAX THERAPEUTICS, INC.
2/20
04:02 pm
tenx
Form SC 13G TENAX THERAPEUTICS, INC. Filed by: S.H.N. Financial Investments Ltd.
Medium
Report
Form SC 13G TENAX THERAPEUTICS, INC. Filed by: S.H.N. Financial Investments Ltd.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register